Carradori et al. (2022) highlights the importance of MAO inhibition in the context of neurodegeneration, with compound 4 exhibiting high selectivity for MAO-B, which is of particular relevance in the context of diseases such as Parkinson’s [286]. The gene discussed is MAOB; the disease is Parkinson disease.